Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Supernus Pharmaceuticals sell melinda

Supernus Pharmaceuticals
Start price
€6.88
27.01.14 / 50%
Target price
€5.00
28.07.14
Performance (%)
-1.37%
End price
€6.79
28.07.14
Summary
This prediction ended on 28.07.14 with a price of €6.79. With a performance of -1.37%, the SELL prediction for Supernus Pharmaceuticals by melinda was down slightly. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Supernus Pharmaceuticals -4.839% -4.839% -12.593% -7.087%
iShares Core DAX® 1.175% -0.931% 13.543% 15.250%
iShares Nasdaq 100 1.232% 9.715% 34.899% 52.433%
iShares Nikkei 225® 1.563% 3.040% 8.943% 6.828%
iShares S&P 500 0.034% 5.962% 27.285% 45.090%

According to melinda what are the pros and cons of Supernus Pharmaceuticals for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Supernus Pharmaceuticals diskutieren
Prediction Sell
Perf. (%) -1.37%
Target price 5.000
Change
Ends at 28.07.14

verkaufen

Ziel erreicht

melinda 
0
Report Share
27.01.14
Prediction Sell
Perf. (%) -1.37%
Target price 5.000
Change
Ends at 28.07.14

(Laufzeit überschritten)

melinda 
0
Report Share
28.07.14

Stopped prediction by melinda for Supernus Pharmaceuticals

buy
Supernus Pharmaceuticals

Start price
Target price
Perf. (%)
€25.20
25.01.21
€28.00
25.01.22
3.97%
26.01.22

Could be worthwhile Investment >10% per year
melinda 
25.01.21 50%
buy
Supernus Pharmaceuticals

Start price
Target price
Perf. (%)
€43.88
09.08.18
€53.94
09.08.19
-41.09%
09.08.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%